Publications

iMTA has been at the frontier of health technology assessment in research for over 25 years. We collaborate with all health care stakeholders, while maintaining independence and always publishing results. Find our work below.

COMPAR-EU Recommendations on Self-Management Interventions in Type 2 Diabetes Mellitus [View]

Jessica Beltran, Claudia Valli, Melixa Medina-Aedo, Carlos Canelo-Aybar, Ena Niño de Guzmán, Yang Song, Carola Orrego, Marta Ballester, Rosa Suñol, Janneke Noordman, Monique Heijmans, Georgios Seitidis, Sofia Tsokani, Katerina Maria Kontouli, Christos Christogiannis, Dimitris Mavridis, Gimon de Graaf, et al (2024). COMPAR-EU Recommendations on Self-Management Interventions in Type 2 Diabetes Mellitus. Healthcare 12(4), 483. Doi.org/10.3390/healthcare12040483

Broadening the HTA of medical AI: A review of the literature to inform a tailored approach [View]

Bart-Jan Boverhof, W. Ken Redekop, Jacob J. Visser, Carin A. Uyl-de Groot, Maureen P.M.H. Rutten-van Mölken (2024). Broadening the HTA of medical AI: A review of the literature to inform a tailored approach. Health Policy and Technology 13(2). Doi: 10.1016/j.hlpt.2024.100868.

Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis [View]

Sofia Tsokani, Georgios Seitidis, Christos Christogiannis, Katerina Maria Kontouli, Stavros Nikolakopoulos, Stella Zevgiti, Carola Orrego, Marta Ballester, Rosa Suñol, Monique Heijmans, Rune Poortvliet, Marieke van der Gaag, Pablo Alonso-Coello, Carlos Canelo-Aybar, Jessica Beltran, Ana I. González-González, Gimon de Graaf, Areti Angeliki Veroniki, Dimitrios Mavridis (2023). Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Healthcare 12(1), 27. Doi.org/10.3390/healthcare12010027.

How Do Patients With Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews [View]

Ena Niño-de-Guzmán, Javier Bracchiglione, Adrián Vásquez-Mejía, Gimon de Graaf, Claudio Rocha Calderón, Pablo Alonso-Coello (2024). How Do Patients with Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews. Value in Health 26(12). Doi.org/10.1016/j.jval.2023.07.003

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options [View]

Koleva‑Kolarova1 R, Buchanan J, Vellekoop H, Huygens S, Versteegh M, Rutten-van Mölken M, Szilberhorn L, Zelei T, Nagy B,  Wordsworth S, Tsiachristas A, on behalf of The HEcoPerMed Consortium (2022). Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options. Applied Health Economics and Health Policy. Doi: 10.1007/s40258-021-00714-9

The Net Benefit of Personalized Medicine: a Systematic Literature Review and Regression Analysis [View]

Vellekoop H, Versteegh M, Huygens S, Wordsworth S, Rutten-van Mölken M, HEcoPerMed consortium (2022). The Net Benefit of Personalized Medicine: a Systematic Literature Review and Regression Analysis. Value in Health. Doi: 10.1016/j.jval.2022.01.006

A Systematic Review of Cost-Effectiveness Studies of Interventions with a Personalized Nutrition Component in Adults [View]

Galekop M, Uyl-de Groot CA, Redekop WK (2021). A Systematic Review of Cost-Effectiveness Studies of Interventions with a Personalized Nutrition Component in Adults. Value in Health 24(3): 325-335. Doi: 10.1016/j.jval.2020.12.006

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future [View]

Heine R, Thielen FW, Koopmanschap M, Kersten MJ, Einsele H, Jaeger U, Sonneveld P, Sierra J Smand C, Uyl-de Groot CA (2021). Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future. HemaSphere 5(2): e524. Doi: 10.1097/HS9.0000000000000524

Health Economic Aspects of Chimeric Antigen Receptor T-Cell Therapies for Haematological Cancers: Present and Future [View]

Heine R, Thielen FW, Koopmanschap M, Kersten MJ, Einsele H, Jaeger U, Sonneveld P, Smand C, Uyl-de Groot CA (2021). Health Economic Aspects of Chimeric Antigen Receptor T-Cell Therapies for Haematological Cancers: Present and Future. Hemasphere 5(2);524. Doi: 10.1097/HS9.0000000000000524

A systematic review of hospital-at-home care: cost savings are overestimated [View]

Goossens, L.M.A., Vemer, P. & Rutten – van Molken, M.P.M.H. (2020). A systematic review of hospital-at-home care: cost savings are overestimated. International Journal of Nursing Studies 109. Doi: 10.1016/j.ijnurstu.2020.103652